中国血液净化

›› 2003, Vol. 2 ›› Issue (6): 298-300.

• 论著 • 上一篇    下一篇

血液透析患者静脉应用左旋肉碱（可益能）的药代动力学研究

刘惠兰 张晓洁 曹 峰   

  1. 100038 北京，首都医科大学附属复兴医院肾内科(刘惠兰， 张晓洁)， 临床药理实验室(曹 峰)
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2003-06-19 发布日期:2003-06-19

  • Received:1900-01-01 Revised:1900-01-01 Online:2003-06-19 Published:2003-06-19

RichHTML

1

PDF

226

摘要： 目的 研究血液透析患者静脉应用左旋肉碱的药代动力学特点，探讨治疗肉碱缺乏的给药途 径、剂量、疗程。方法 选择9例本透析中心病情稳定的患者，男5例，女4例。于每次血液透析结束回血前3分钟，静脉推注1g左旋肉碱，共用药8周（26次透析）。应用酶法检测首次给药前（0时）、给药后1.5分钟、3分钟、15分钟、30分钟、1小时、2小时、4小时、8小时、12小时、24小时肉碱的血药浓度，分析单次静脉应用左旋肉碱的药代动力学特点。另外，于首次给药、给药2周、4周、6周、8周分别检测透析前后、透析液中肉碱浓度，研究多次用药后血浆肉碱水平变化和透析液中的清除量。结果 维持性血液透析患者用药前血浆肉碱浓度大大低于正常值40～50umol/L；首次于透析结束时静脉给予1g左旋肉碱的药代动力学符合二室开放模型。给药后血药浓度很快增加，然后迅速下降，AUC大，但半衰期与正常人接近；每次透析过程中均可清除大量的肉碱，并且随着血药浓度增加而清除增加；连续给药期6至8周后透析前后肉碱水平基本维持稳定。结论 血液透析患者外源性补充肉碱的药代动力学特点与正常人不同，透析清除是药物排泄的主要途径，因此须6～8周连续透析后补充用药，使组织及血浆肉碱水平恢复。

关键词: 左旋肉碱, 血液透析, 药代动力学

Abstract: Objective To evaluate the pharmacokinetic characters of intravenous administered L-carnitine in hemodialysis patients. Methods One gram L-carnitine was given by intravenous after hemodialysis in 9 patients, blood samples were taken at 0, 1.5, 3, 15min and 0.5、1、2、4、8、12、24h to investigate the pharmacokinetic parameters for single dose L-carnitine. Then study the carnitine levels in plasma before /after hemodialysis and in hemodialysates at 0、2、4、6、8 weeks during. Results The plasma carnitine level were lower than normal in hemodialysis patients； The pharmacokinetic parameters for single dose L-carnitine were fitted two-compartment open model； L-carnitine conformed to during hemodialysis greatly；After repeated administration of L-carnitine for 6～8 weeks, the plasma carnitine level can keep stable. Conclusion The pharmacokinetic characters of intravenous administered L-carnitine in hemodialysis patients were different from normal. L-carnitine was significantly eliminated to hemodialysate, so repeated supplementations were needed for 6～8 weeks after each hemodialysis. 

Key words: Hemodialysis, Pharmacokinetics